1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Drug Delivery Insight 15 DECEMBER 2014

Drug Delivery Insight 15 DECEMBER 2014

  • December 2014
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - ADCs Continue To Offer Promise Within Oncology Setting
Industry Trend Analysis - Takeda's Oncology Rebranding To Reinforce Global Position
Industry Brief - Dymista Litigation Against Apotex Initiated In US
Industry Brief - Dynavax/AstraZeneca To Advance AZD1419 Into Phase IIa Asthma Study
Industry Brief - Zosano/Lilly Sign ZP-PTH Licensing Deal For Osteoporosis
Industry Brief - Eli Lilly/Acrux File Axiron Patent Litigation Against Amneal
Industry Brief - FDA Approval For Animas Vibe Insulin Pump With CGM
Industry Brief - Iluvien Approved For Sale In The Netherlands
Industry Brief - AcelRx Receives CE Mark Approval For Zalviso
Industry Brief - Pfizer Launches Ultibro Breezhaler In UK
Industry Brief - FDA Approves PulmoFlow's Kitabis Pak NDA
Industry Brief - FDA Approves Two Higher Dosage Strengths Of Zubsolv
Industry Brief - Teikoku Reports Positive Study Results Of Seven-Day Patch For PD
Industry Brief - Cardionovum Initiates Aperto DCB Clinical Study
Industry Brief - OncoSec Initiates ImmunoPulse SCCHN Phase II Trial
Industry Brief - Phase III Trial Of Acorda's CVT-301 In PD Initiated

Table Of Contents

Drug Delivery Insight 15 DECEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.